20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand
Go back to 20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand| (NASDAQ: AIDX) | Delayed: 0.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.61 | 52 Week High | $ | |||
| Open | $0.61 | 52 Week Low | $ | |||
| Day High | $0.61 | P/E | N/A | |||
| Day Low | $0.61 | EPS | $ | |||
| Volume | 20,243 | |||||

